TG Therapeutics TGTX Operating Cash Flow
Operating Cash Flow at other companies
Other financials
Where this comes from
Reported directly by TG Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.
The official record: TG Therapeutics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about TG Therapeutics's operating cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is TG Therapeutics's operating cash flow?
- TG Therapeutics (TGTX) reported operating cash flow of -$17.89M in Q1 2026.
- How has TG Therapeutics's operating cash flow changed year-over-year?
- TG Therapeutics's operating cash flow increased by 37.7% year-over-year, from -$28.72M to -$17.89M.
- What does operating cash flow mean?
- The net amount of cash a company generates from its primary business activities.
- How do you interpret operating cash flow?
- Positive and growing cash flow indicates a healthy, self-sustaining business, while negative cash flow may signal a need for external funding.
- How does operating cash flow compare across companies?
- The gold standard for assessing operational health across all public companies.